Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.280
0.00 (0.00%)
At close: Jan 17, 2025, 4:00 PM
1.270
-0.010 (-0.78%)
After-hours: Jan 17, 2025, 6:28 PM EST
Repare Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 66.52 | 51.13 | 131.83 | 7.6 | 0.14 | - | |
| Revenue Growth (YoY) | 18.19% | -61.21% | 1634.61% | 5529.63% | - | - | |
| Cost of Revenue | 124.32 | 131.2 | 116.72 | 87.85 | 38.78 | 20.28 | |
| Gross Profit | -57.8 | -80.07 | 15.11 | -80.25 | -38.64 | -20.28 | |
| Selling, General & Admin | 34.42 | 36.15 | 34.9 | 28.41 | 15.66 | 6.1 | |
| Operating Expenses | 34.42 | 36.15 | 34.9 | 28.41 | 15.66 | 6.1 | |
| Operating Income | -92.22 | -116.22 | -19.8 | -108.66 | -54.3 | -26.38 | |
| Interest & Investment Income | 11.48 | 13.33 | 5.63 | 0.26 | 0.24 | - | |
| Currency Exchange Gain (Loss) | -0.02 | -0.17 | 0.31 | -0.14 | -0.66 | 0.71 | |
| Other Non Operating Income (Expenses) | -0.14 | -0.12 | -0.04 | -0.04 | -0.02 | -1.36 | |
| EBT Excluding Unusual Items | -80.89 | -103.18 | -13.9 | -108.59 | -54.74 | -27.02 | |
| Pretax Income | -82.42 | -103.18 | -13.9 | -108.59 | -54.74 | -27.02 | |
| Income Tax Expense | 1.63 | -9.38 | 15.15 | -1.68 | -1.33 | 0.2 | |
| Net Income | -84.05 | -93.8 | -29.05 | -106.91 | -53.42 | -27.22 | |
| Net Income to Common | -84.05 | -93.8 | -29.05 | -106.91 | -53.42 | -27.22 | |
| Shares Outstanding (Basic) | 42 | 42 | 42 | 38 | 20 | 2 | |
| Shares Outstanding (Diluted) | 42 | 42 | 42 | 38 | 20 | 2 | |
| Shares Change (YoY) | 0.63% | 0.41% | 10.85% | 88.66% | 1211.56% | - | |
| EPS (Basic) | -1.99 | -2.23 | -0.69 | -2.83 | -2.66 | -17.81 | |
| EPS (Diluted) | -1.99 | -2.23 | -0.69 | -2.83 | -2.66 | -17.81 | |
| Free Cash Flow | -77.68 | -129.1 | -0.28 | -87.49 | -8.32 | -19.73 | |
| Free Cash Flow Per Share | -1.84 | -3.07 | -0.01 | -2.31 | -0.42 | -12.91 | |
| Gross Margin | -86.88% | -156.59% | 11.46% | - | - | - | |
| Operating Margin | -138.62% | -227.30% | -15.02% | -1429.74% | -40223.70% | - | |
| Profit Margin | -126.34% | -183.44% | -22.03% | -1406.68% | -39568.15% | - | |
| Free Cash Flow Margin | -116.76% | -252.47% | -0.21% | -1151.13% | -6163.70% | - | |
| EBITDA | -90.24 | -114.27 | -17.82 | -107.19 | -53.41 | -25.77 | |
| EBITDA Margin | -135.65% | -223.48% | -13.52% | - | - | - | |
| D&A For EBITDA | 1.97 | 1.95 | 1.98 | 1.47 | 0.9 | 0.61 | |
| EBIT | -92.22 | -116.22 | -19.8 | -108.66 | -54.3 | -26.38 | |
| EBIT Margin | -138.62% | -227.30% | -15.02% | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.